The lateral flow, fingerprick blood test measures monoclonal proteins, with results that can be read on a phone app.

The test, which aids in the detection of the brain amyloid pathology characteristic of Alzheimer's, is the first blood test cleared by FDA for use in diagnosing the disease.

The partners will study the use of a test for Ly6E(hi) neutrophils as a biomarker for treatment response in five cancer indications.

NEW YORK — MDxHealth on Wednesday posted a 22 percent year-over-year increase in its first quarter revenues, topping Wall Street's consensus estimate. For the three-month period ended March 31, ...

The test detects the MET protein that is over-expressed in some patients with non-squamous non-small cell lung cancer.

Upfront will use the proceeds to accelerate the commercialization of its lateral flow test, called LVOne, for triaging stroke ...

NEW YORK – Targeted Genomics on Wednesday announced a commercial collaboration with OraSure Technologies for direct-to-consumer celiac disease testing using the OraCollect-Dx saliva collection device ...

EsoGuard esophageal precancer testing volume rose 25 percent to 3,034 tests in the first quarter compared to 2,420 tests in Q1 2024.